Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-028353
Filing Date
2025-02-27
Accepted
2025-02-27 07:12:56
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tngx-20241231.htm   iXBRL 10-K 3198839
2 EX-19.1 tngx-ex19_1.htm EX-19.1 105829
3 EX-23.1 tngx-ex23_1.htm EX-23.1 2484
4 EX-31.1 tngx-ex31_1.htm EX-31.1 16563
5 EX-31.2 tngx-ex31_2.htm EX-31.2 16452
6 EX-32.1 tngx-ex32_1.htm EX-32.1 7936
7 EX-32.2 tngx-ex32_2.htm EX-32.2 7927
8 GRAPHIC img160986081_0.jpg GRAPHIC 83619
9 GRAPHIC img160986081_1.jpg GRAPHIC 41849
10 GRAPHIC img160986081_2.jpg GRAPHIC 63512
11 GRAPHIC img160986081_3.jpg GRAPHIC 53514
12 GRAPHIC img160986081_4.jpg GRAPHIC 68862
13 GRAPHIC img160986081_5.jpg GRAPHIC 386627
14 GRAPHIC img160986081_6.jpg GRAPHIC 100405
15 GRAPHIC img160986081_7.jpg GRAPHIC 103583
16 GRAPHIC img160986081_8.jpg GRAPHIC 93745
  Complete submission text file 0000950170-25-028353.txt   14733485

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tngx-20241231.xsd EX-101.SCH 1621093
100 EXTRACTED XBRL INSTANCE DOCUMENT tngx-20241231_htm.xml XML 2121580
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39485 | Film No.: 25672976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)